Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.
NVS Key Statistics
Stock Snapshot
With a market cap of 278.62B, Novartis(NVS) trades at $131.98. The stock has a price-to-earnings ratio of 17.78 and currently yields dividends of 2.5%.
During the trading session on 2025-11-18, Novartis(NVS) shares reached a daily high of $133.18 and a low of $131.39. At a current price of $131.98, the stock is +0.4% higher than the low and still -0.9% under the high.
Trading activity shows a volume of 1.74M, compared to an average daily volume of 1.45M.
Over the past 52 weeks, Novartis(NVS) stock has traded between a high of $134.00 and a low of $96.06.
Over the past 52 weeks, Novartis(NVS) stock has traded between a high of $134.00 and a low of $96.06.
NVS News
Novartis AG (NYSE:NVS) released data on Thursday from the KALUMA Phase 3 study for the new malaria treatment KLU156 (ganaplacide/lumefantrine, or GanLum). GanL...
Novartis (NVS) (OTCPK:NVSEF) has announced that its next-generation malaria treatment, KLU156 (GanLum), developed with Swiss nonprofit Medicines for Malaria Ven...
Novartis (NVS) announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156. The novel non-artemisinin antimalarial, which was dev...
Analyst ratings
57%
of 28 ratingsMore NVS News
Shares in Swiss pharmaceutical giant Novartis (NVS) were looking healthier today after hailing a generational breakthrough in the battle against the deadly mala...
In recent trading, shares of Novartis AG Basel (Symbol: NVS) have crossed above the average analyst 12-month target price of $127.00, changing hands for $127.11...
